Antagonistic immune signals arbitrated by cytoplasmic lipid droplet dynamic in IBD

Ended Project Grant Awarded Last action

Award ID
W81XWH2110074
Recipient
Awarding agency
Obligated
$332,648

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Boston, MA 02114, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Massachusetts General Hospital was awarded a $332,648 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from January 2021 to January 2023 to investigate antagonistic immune signals arbitrated by cytoplasmic lipid droplet dynamics in inflammatory bowel disease. Through this award, the awardee aims to transform health care for service members and the public by advancing understanding of medical solutions for the battlefield and investigating innovative treatments for inflammatory bowel diseases. The research will be performed at the Massachusetts General Hospital in Boston, Massachusetts.

Quick answers

Who received award W81XWH2110074?

W81XWH2110074 was awarded to The General Hospital Corporation by Medical Command (Department of the Army) on January 15, 2021.

How much is award W81XWH2110074 worth?

$332,648 has been obligated on W81XWH2110074.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login